Here's a concise, retail-friendly summary: **Business Performance:** PCCPL delivered a strong Q1FY27 with revenue up 9% YoY to ₹347 Cr, primarily boosted by export sales.

New products are a key driver, making up 14% of revenue and growing 40% YoY. **Growth Drivers or Strategy:** The company is diversifying its portfolio across agrochemicals, pharma, and industrial chemicals.

Strategy focuses on expanding CDMO business, backward integration, and developing high-value intermediates and catalogue products to enhance margins. **Recent Developments:** Key progress includes commercializing new agro intermediate capacity, targeting 100% volume growth this year.

Supplied initial lots for 2 of 3 MoU products; volumes expected from Q4FY27. Two new herbicide products are also planned for Q3/Q4FY27 launch. **Key Financial Metrics:** Profits impressed!

EBITDA soared 18.8% YoY to ₹41 Cr (11.8% margin). Profit After Tax (PAT) rose 7% YoY to ₹22 Cr (6.4% margin). Gross margins also improved to 36.6%. **Management Commentary / Outlook:** PCCPL plans ~₹100 Cr capex for two new plants over 2-3 years, focusing on export expansion and exploring a new production site.

They project ₹120-150 Cr incremental revenue from new products in 2-3 years, backed by doubling R&D spend.